Goldman Sachs’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,501
| Closed | -$26.8K | – | 5088 |
|
|
2024
Q4 | $26.8K | Buy |
+2,501
| New | +$26.8K | ﹤0.01% | 4890 |
|
|
2023
Q3 | – | Sell |
-14,209
| Closed | -$364K | – | 4743 |
|
|
2023
Q2 | $364K | Buy |
14,209
+55
| +0.4% | +$1.41K | ﹤0.01% | 4136 |
|
|
2023
Q1 | $393K | Buy |
14,154
+3
| +0% | +$83 | ﹤0.01% | 4202 |
|
|
2022
Q4 | $368K | Buy |
14,151
+13,544
| +2,231% | +$352K | ﹤0.01% | 4249 |
|
|
2022
Q3 | $18K | Sell |
607
-1,081
| -64% | -$32.1K | ﹤0.01% | 5187 |
|
|
2022
Q2 | $69K | Sell |
1,688
-626
| -27% | -$25.6K | ﹤0.01% | 5211 |
|
|
2022
Q1 | $126K | Sell |
2,314
-21,681
| -90% | -$1.18M | ﹤0.01% | 5241 |
|
|
2021
Q4 | $2.35M | Buy |
23,995
+1,857
| +8% | +$182K | ﹤0.01% | 3386 |
|
|
2021
Q3 | $5.6M | Buy |
22,138
+52
| +0.2% | +$13.2K | ﹤0.01% | 2711 |
|
|
2021
Q2 | $6.83M | Buy |
22,086
+10,662
| +93% | +$3.3M | ﹤0.01% | 2555 |
|
|
2021
Q1 | $7.52M | Buy |
+11,424
| New | +$7.52M | ﹤0.01% | 2397 |
|